MGI Tech Overview
- Year Founded
-
2016
- Status
-
Public
- Employees
-
2,195
- Stock Symbol
-
688114
- Investments
-
6
- Share Price
-
$7.50
- (As of Thursday Closing)
MGI Tech General Information
Description
MGI Tech Co Ltd is a producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation. It provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision agriculture, precision healthcare, and other relevant industries.
Contact Information
Website
www.mgi-tech.comCorporate Office
- Number 146, Beishan Road
- Yantian District
- Shenzhen, Guangdong 518083
- China
Corporate Office
- Number 146, Beishan Road
- Yantian District
- Shenzhen, Guangdong 518083
- China
MGI Tech Stock Performance
As of 19-Nov-2026, MGI Tech’s stock price is $7.50. Its current market cap is $3.13B with 417M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.50 | $7.59 | $6.63 - $11.97 | $3.13B | 417M | 9.5M | -$0.07 |
MGI Tech Financials Summary
As of 30-Sep-2026, MGI Tech has a trailing 12-month revenue of $437M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 4,124,506 | 3,318,430 | 2,255,103 | 4,367,915 |
| Revenue | 436,633 | 386,524 | 419,838 | 411,487 |
| EBITDA | (23,573) | 18,067 | (23,801) | (55,692) |
| Net Income | (27,531) | (30,890) | (83,734) | (85,867) |
| Total Assets | 1,490,647 | 1,458,107 | 1,412,975 | 1,489,305 |
| Total Debt | 205,834 | 143,369 | 100,794 | 57,611 |
MGI Tech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MGI Tech Comparisons
Industry
Financing
Details
MGI Tech Competitors (14)
One of MGI Tech’s 14 competitors is RareCyte, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RareCyte | Venture Capital-Backed | Seattle, WA | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Novogene | Formerly PE-Backed | Beijing, China | ||||
| Otogenetics | Corporation | Atlanta, GA |
MGI Tech Patents
MGI Tech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026228835-A1 | Dna fragment sequencing library having a predetermined size range made by controlled primer extension (cpe) | Pending | 02-May-2025 | ||
| WO-2026227266-A1 | Gene sequencing system, gene sequencing method, and sample carrier | Pending | 28-Apr-2025 | ||
| WO-2026222776-A1 | Biochemical reaction system and method, gene sequencing apparatus, and gene sequencing method | Pending | 25-Apr-2025 | ||
| WO-2026222668-A1 | Fluid loading method and system, and gene sequencing method and system | Pending | 23-Apr-2025 | ||
| WO-2026207868-A1 | Method for determining length of single-base repeat sequence | Pending | 03-Apr-2025 |
MGI Tech Signals
MGI Tech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MGI Tech Investments & Acquisitions (6)
MGI Tech’s most recent deal was a Merger/Acquisition with Huada Xufeng. The deal was made on 09-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Huada Xufeng | 09-Mar-2026 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| STOmics | 03-Mar-2026 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Aurefluidics Technology | 13-Nov-2023 | Later Stage VC | Other Pharmaceuticals and Biotechnology | ||
| Genepoint | 12-Jul-2021 | Later Stage VC | Drug Delivery | ||
| Rob Medical | 31-Dec-2018 | Corporate | Computers, Parts and Peripherals |
MGI Tech ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
28.24 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
MGI Tech Exits (2)
MGI Tech’s most recent exit was on 31-Dec-2018 from Rob Medical. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Rob Medical | 31-Dec-2018 | Completed |
|
||
| Rob Medical | 01-Sep-2017 | Corporate | Completed |
MGI Tech Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Huada Xufeng | Hangzhou, China | 2024 | |
| STOmics | Shenzhen, China | 2024 |
MGI Tech FAQs
-
When was MGI Tech founded?
MGI Tech was founded in 2016.
-
Where is MGI Tech headquartered?
MGI Tech is headquartered in Shenzhen, China.
-
What is the size of MGI Tech?
MGI Tech has 2,195 total employees.
-
What industry is MGI Tech in?
MGI Tech’s primary industry is Biotechnology.
-
Is MGI Tech a private or public company?
MGI Tech is a Public company.
-
What is MGI Tech’s stock symbol?
The ticker symbol for MGI Tech is 688114.
-
What is the current stock price of MGI Tech?
As of 19-Nov-2026 the stock price of MGI Tech is $7.50.
-
What is the current market cap of MGI Tech?
The current market capitalization of MGI Tech is $3.13B.
-
What is MGI Tech’s current revenue?
The trailing twelve month revenue for MGI Tech is $437M.
-
Who are MGI Tech’s competitors?
RareCyte, Illumina, Foundation Medicine, Novogene, and Otogenetics are some of the 14 competitors of MGI Tech.
-
What is MGI Tech’s annual earnings per share (EPS)?
MGI Tech’s EPS for 12 months was -$0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process